A Study to Evaluate Vinorelbine Plus Capecitabine Combined With Trastuzumab for HER2 Positive Patients Following Neoadjuvant Chemotherapy
Clinical trial NCT04302441 · UNKNOWN
Trial details
- NCT number
- NCT04302441
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-10
- Primary completion
- 2021-06-30
- Enrollment
- 550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.